Ashurst Perkins Coie opens its doors following landmark merger ...

Despite the flexibilities embedded in the TRIPS Agreement and reaffirmed by the Doha Declaration, timely access to vaccines ...

15 June 2026 Highly experienced partner is the second big name to join the firm this year, expanding its Engineering & Tech ...

Deal is aimed at strengthening German company’s presence across high-growth life sciences markets by adding a portfolio of advanced research and analytical technologies.

Despite a slowdown in US patent litigation, life sciences remains one of the most active sectors—but companies are using a ...

16 June 2026 In the second of a series of interviews with women judges at the pan-European court, Ulrike Voß talks to Sarah ...

The court granted Blue Cross Laboratories a permanent injunction after finding that a rival product’s mark and packaging closely mirrored its own.

Rodic, Patent Strategist-in-Chief at Hylton-Rodic Law, moderates a discussion with Giulia Toti, Head of GTM & Life Sciences ...

A cancer diagnostics company has lost its bid to overturn a jury verdict in a major patent dispute that has also spawned ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

The panel has been chosen. With judges from Amgen, Pfizer, Eli Lilly, Takeda, Regeneron and law firms such as White & Case and Arnold & Porter, here’s who will be deciding this year’s winners. LSIPR’s ...

In the first of a two-part series, Mercedes Meyer of Banner Witcoff and Brandon Phemester of Novavax explore how legislative, judicial, and executive policies have dramatically altered the risks for ...